Sign in

CIK 0000886744

  • Large accelerated filer
Ticker
GERN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
752287752
Phone
+1 650-473-7700
Business address
919 EAST HILLSDALE BOULEVARD, SUITE 250, FOSTER CITY, CA, 94404
Former names
GERON CORPORATION
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Planned sale Director sold 35,000 shares at $3.00 ($105,000)
  4. 4 Open-market sale Director sold 35,000 shares at $2.48 ($86,800)
  5. 4 Grant or award Director acquired 6,048 shares (grant or award)
  6. 4 Grant or award Director acquired 3,312 shares (grant or award)
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Open-market sale EVP, Chief Operating Officer sold 384,719 shares at $3.03 ($1,165,699)
  13. 4 Open-market sale EVP, Chief Financial Officer sold 400,000 shares at $3.08 ($1,232,000)
  14. 4 Open-market sale Chairman, President and CEO sold 1,340,000 shares at an average $3.04 ($4,069,133)
  15. 4 Option exercise Director acquired 35,000 shares (option exercise)
  16. 4 Grant or award EVP, Corp Strategy & CCO acquired 6,021 shares (grant or award)
  17. 4 Grant or award Director acquired 2,970 shares (grant or award)
  18. 4 Grant or award Director acquired 3,071 shares (grant or award)
  19. 4 Option exercise EVP, Chief Operating Officer acquired 234,719 shares (option exercise)
  20. 4 Derivatives Options or other derivatives

Page 6 of 35 · 692 filings